MXPA01006823A - Preparacion y uso de radio-223 para marcar tejidos calcificados para el alivio del dolor, terapia para el cancer de huesos, y acondicionamiento de la superficie de los huesos. - Google Patents
Preparacion y uso de radio-223 para marcar tejidos calcificados para el alivio del dolor, terapia para el cancer de huesos, y acondicionamiento de la superficie de los huesos.Info
- Publication number
- MXPA01006823A MXPA01006823A MXPA01006823A MXPA01006823A MXPA01006823A MX PA01006823 A MXPA01006823 A MX PA01006823A MX PA01006823 A MXPA01006823 A MX PA01006823A MX PA01006823 A MXPA01006823 A MX PA01006823A MX PA01006823 A MXPA01006823 A MX PA01006823A
- Authority
- MX
- Mexico
- Prior art keywords
- bone
- radium
- preparation
- cancer therapy
- surface conditioning
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title abstract 3
- 208000018084 Bone neoplasm Diseases 0.000 title abstract 2
- HCWPIIXVSYCSAN-OIOBTWANSA-N radium-223 Chemical compound [223Ra] HCWPIIXVSYCSAN-OIOBTWANSA-N 0.000 title abstract 2
- 229960005562 radium-223 Drugs 0.000 title abstract 2
- 206010005949 Bone cancer Diseases 0.000 title 1
- 230000003750 conditioning effect Effects 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
- 210000001519 tissue Anatomy 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000004872 soft tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Radiation-Therapy Devices (AREA)
- Compounds Of Unknown Constitution (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Biological Depolymerization Polymers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO990001A NO310544B1 (no) | 1999-01-04 | 1999-01-04 | Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben |
| PCT/NO1999/000392 WO2000040275A2 (en) | 1999-01-04 | 1999-12-17 | The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01006823A true MXPA01006823A (es) | 2003-07-14 |
Family
ID=19902803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01006823A MXPA01006823A (es) | 1999-01-04 | 1999-12-17 | Preparacion y uso de radio-223 para marcar tejidos calcificados para el alivio del dolor, terapia para el cancer de huesos, y acondicionamiento de la superficie de los huesos. |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US6635234B1 (enExample) |
| EP (1) | EP1140212B1 (enExample) |
| JP (2) | JP4649044B2 (enExample) |
| KR (1) | KR100671387B1 (enExample) |
| CN (2) | CN1194764C (enExample) |
| AT (1) | ATE331534T1 (enExample) |
| AU (1) | AU774991B2 (enExample) |
| BE (1) | BE2014C028I2 (enExample) |
| BR (1) | BR9916768A (enExample) |
| CA (1) | CA2358498C (enExample) |
| CY (2) | CY1105634T1 (enExample) |
| DE (1) | DE69932183T2 (enExample) |
| DK (1) | DK1140212T3 (enExample) |
| EA (1) | EA003496B1 (enExample) |
| ES (1) | ES2268888T3 (enExample) |
| IL (1) | IL144135A0 (enExample) |
| LU (1) | LU92425I2 (enExample) |
| MX (1) | MXPA01006823A (enExample) |
| NO (2) | NO310544B1 (enExample) |
| NZ (3) | NZ534618A (enExample) |
| PT (1) | PT1140212E (enExample) |
| TR (3) | TR200201440T2 (enExample) |
| WO (1) | WO2000040275A2 (enExample) |
| ZA (1) | ZA200105431B (enExample) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO310544B1 (no) * | 1999-01-04 | 2001-07-23 | Algeta As | Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben |
| NO314537B1 (no) * | 1999-12-06 | 2003-04-07 | Anticancer Therapeutic Inv Sa | Reseptorbindende konjugater |
| NO313180B1 (no) * | 2000-07-04 | 2002-08-26 | Anticancer Therapeutic Inv Sa | Bensökende alfapartikkel emitterende radiofarmasöytika |
| AUPQ923100A0 (en) * | 2000-08-07 | 2000-08-31 | Peplin Research Pty Ltd | Treatment of prostate cancer |
| WO2003061566A2 (en) * | 2002-01-24 | 2003-07-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Anti-cancer combination and use thereof |
| GB0213261D0 (en) * | 2002-06-10 | 2002-07-17 | Anticancer Therapeutic Inv Sa | Method |
| GB0308731D0 (en) * | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
| ATE424221T1 (de) * | 2003-04-30 | 2009-03-15 | Univ Ramot | Verfahren und vorrichtung für strahlentherapie |
| EA020542B1 (ru) * | 2004-02-20 | 2014-12-30 | Алгета Ас | Альфа-излучающие частицы гидроксиапатита |
| DE102004022200B4 (de) * | 2004-05-05 | 2006-07-20 | Actinium Pharmaceuticals, Inc. | Radium-Target sowie Verfahren zu seiner Herstellung |
| US7914766B1 (en) * | 2004-06-03 | 2011-03-29 | Ut-Battelle Llc | Inorganic resins for clinical use of 213Bi generators |
| GB0423565D0 (en) * | 2004-10-22 | 2004-11-24 | Algeta As | Formulation |
| HUE037796T2 (hu) * | 2005-07-26 | 2018-09-28 | Aplha Tau Medical Ltd | Radioaktív felületi forrás és eljárás elõállítására |
| US8709380B1 (en) * | 2006-02-07 | 2014-04-29 | Sirius Medicine, Llc | Targeting agents for enhancing radiation therapy |
| DE102006008023B4 (de) | 2006-02-21 | 2008-05-29 | Actinium Pharmaceuticals, Inc. | Verfahren zum Reinigen von 225Ac aus bestrahlten 226Ra-Targets |
| EP2796575B8 (en) * | 2006-09-08 | 2020-04-01 | Actinium Pharmaceuticals, Inc. | Method for the purification of radium from different sources |
| EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
| EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
| EP2353591A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
| GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
| GB201007353D0 (en) * | 2010-04-30 | 2010-06-16 | Algeta Asa | Method |
| GB201007354D0 (en) | 2010-04-30 | 2010-06-16 | Algeta Asa | Method |
| EP2388005A1 (en) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| EP2415471A1 (en) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in opioid-induced hyperalgesia |
| EP2524694A1 (en) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in diabetes type-2 associated pain |
| US20150343099A1 (en) | 2012-12-19 | 2015-12-03 | Bayer Pharma Aktiengesellschaft | Combination comprising radium-223 for the treatment of cancer |
| GB201314718D0 (en) * | 2013-08-16 | 2013-10-02 | Algeta As | Quantification method |
| WO2015082378A1 (en) | 2013-12-03 | 2015-06-11 | Bayer Pharma Aktiengesellschaft | Combination of pi3k-inhibitors |
| CN105934256B (zh) | 2013-12-03 | 2019-12-27 | 拜耳制药股份公司 | Pi3k-抑制剂的组合产品 |
| SG11201604480PA (en) | 2013-12-17 | 2016-07-28 | Esteve Labor Dr | SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS |
| WO2016083739A1 (fr) | 2014-11-26 | 2016-06-02 | Rhodia Operations | Composition de lanthane et d'actinium-227 |
| GB201600153D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope preparation method |
| GB201600154D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope preparation method |
| CZ307369B6 (cs) * | 2016-12-22 | 2018-07-04 | České vysoké učení technické v Praze | Kombinace pro radionuklidovou terapii pro použití jako léčivo |
| WO2018153969A1 (en) | 2017-02-24 | 2018-08-30 | Bayer Aktiengesellschaft | Combination of atr kinase inhibitors with radium-223 salt |
| SG11201910176PA (en) | 2017-05-11 | 2019-11-28 | Alpha Tau Medical Ltd | Polymer coatings for brachytherapy devices |
| WO2019193464A1 (en) | 2018-04-02 | 2019-10-10 | Alpha Tau Medical Ltd. | Controlled release of radionuclides |
| EP3563875A1 (en) * | 2018-05-04 | 2019-11-06 | Ceské vysoké ucení technické v Praze | Radium for radionuclide therapy, in combination with calcium metabolism affecting treatment |
| LU100900B1 (de) * | 2018-08-10 | 2020-02-17 | Thomas Melchior Homann | Verbindungen zur modulation von a-ketoglutarsäure (2kg)-abhängigen oxygenasen |
| FR3086186B1 (fr) * | 2018-09-26 | 2022-01-28 | Orano Med | Procede de production de plomb-212 a partir d'une solution aqueuse comprenant du thorium-228 et ses descendants |
| FR3088769B1 (fr) * | 2018-11-15 | 2020-12-25 | Orano Med | Procede de preparation d'au moins un generateur a haute teneur en radium-228 |
| WO2020180756A1 (en) * | 2019-03-01 | 2020-09-10 | Washington University | Compositions and methods for radiotherapy using chelated radiotherapeutic agents and non-target tissue blockade |
| PH12022551370A1 (en) | 2019-12-05 | 2023-05-08 | Sciencons AS | Production of highly purified 212pb |
| RU2752845C1 (ru) * | 2020-05-13 | 2021-08-11 | Акционерное Общество "Наука И Инновации" | Способ получения высокочистого радия-223 |
| IL303002B1 (en) | 2020-12-16 | 2026-08-01 | Alpha Tau Medical Ltd | Radiation therapy using scattered alpha emitters with enhanced beta therapy |
| CN113066598B (zh) * | 2021-03-25 | 2023-08-08 | 中国科学院近代物理研究所 | 一种从高能质子束辐照232Th靶引起的散裂反应中分离纯化223Ra的方法 |
| US12042668B2 (en) | 2021-06-10 | 2024-07-23 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for squamous cell carcinoma |
| US12064643B2 (en) | 2021-06-10 | 2024-08-20 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for breast cancer |
| US11964168B2 (en) | 2021-06-10 | 2024-04-23 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for prostate cancer |
| US12076581B2 (en) | 2021-06-10 | 2024-09-03 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for glioblastoma |
| US12070620B2 (en) | 2021-06-10 | 2024-08-27 | Alpha Tau Medical Ltd. | Activity levels for diffusing alpha-emitter radiation therapy |
| US12070621B2 (en) | 2021-06-10 | 2024-08-27 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for pancreatic cancer |
| US12076582B2 (en) | 2021-06-10 | 2024-09-03 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for colorectal cancer |
| US12076583B2 (en) | 2021-06-10 | 2024-09-03 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for melanoma |
| JP2025507614A (ja) | 2022-02-21 | 2025-03-21 | バイエル・ヘルスケア・エルエルシー | 治療薬または診断薬の送達のためのシステム、方法、およびデバイス |
| WO2023159230A1 (en) | 2022-02-21 | 2023-08-24 | Bayer Healthcare Llc | System, method and device for delivery of a therapeutic or diagnostic agent |
| CN115869658B (zh) * | 2022-12-29 | 2025-01-28 | 中国核动力研究设计院 | 用于制备Ra-223的分离系统及其分离方法、应用和制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH668489A5 (de) * | 1982-01-22 | 1988-12-30 | Vnii Mineralnogo Syrya | Radiometrisches verfahren zur bestimmung der konzentration natuerlicher radiumisotope und einrichtung zur durchfuehrung des verfahrens. |
| AU626348B2 (en) * | 1988-10-14 | 1992-07-30 | Mallinckrodt, Inc. | Radiolabelled particulate composition |
| US4970062A (en) * | 1989-05-30 | 1990-11-13 | The United States Of America As Represented By The United States Department Of Energy | Colloid labelled with radionuclide and method |
| AU3177893A (en) * | 1991-11-14 | 1993-06-15 | Battelle Memorial Institute | Method for diagnosing and treating cancer |
| AU683893B2 (en) * | 1993-05-17 | 1997-11-27 | Immunomedics Inc. | Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| US5809394A (en) * | 1996-12-13 | 1998-09-15 | Battelle Memorial Institute | Methods of separating short half-life radionuclides from a mixture of radionuclides |
| US6117413A (en) * | 1997-11-12 | 2000-09-12 | Battelle Memorial Institute | Radionuclide-binding compound, a radionuclide delivery system, a method of making a radium complexing compound, a method of extracting a radionuclide, and a method of delivering a radionuclide |
| NO310544B1 (no) * | 1999-01-04 | 2001-07-23 | Algeta As | Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben |
| NO314537B1 (no) * | 1999-12-06 | 2003-04-07 | Anticancer Therapeutic Inv Sa | Reseptorbindende konjugater |
| NO312708B1 (no) * | 2000-02-21 | 2002-06-24 | Anticancer Therapeutic Inv Sa | Radioaktive liposomer til terapi |
| NO313180B1 (no) * | 2000-07-04 | 2002-08-26 | Anticancer Therapeutic Inv Sa | Bensökende alfapartikkel emitterende radiofarmasöytika |
| GB0213261D0 (en) * | 2002-06-10 | 2002-07-17 | Anticancer Therapeutic Inv Sa | Method |
| GB0308731D0 (en) * | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
| US20060228297A1 (en) * | 2003-04-15 | 2006-10-12 | Roy Larsen | Thorium-227 for use in radiotherapy of soft tissue disease |
-
1999
- 1999-01-04 NO NO990001A patent/NO310544B1/no not_active IP Right Cessation
- 1999-12-17 TR TR2002/01440T patent/TR200201440T2/xx unknown
- 1999-12-17 BR BR9916768-9A patent/BR9916768A/pt not_active Application Discontinuation
- 1999-12-17 DK DK99960058T patent/DK1140212T3/da active
- 1999-12-17 KR KR1020017008497A patent/KR100671387B1/ko not_active Expired - Fee Related
- 1999-12-17 CA CA002358498A patent/CA2358498C/en not_active Expired - Lifetime
- 1999-12-17 CN CNB998161020A patent/CN1194764C/zh not_active Expired - Lifetime
- 1999-12-17 TR TR2002/01442T patent/TR200201442T2/xx unknown
- 1999-12-17 DE DE69932183T patent/DE69932183T2/de not_active Expired - Lifetime
- 1999-12-17 CN CN2004100749238A patent/CN1767078B/zh not_active Expired - Lifetime
- 1999-12-17 MX MXPA01006823A patent/MXPA01006823A/es active IP Right Grant
- 1999-12-17 EA EA200100642A patent/EA003496B1/ru not_active IP Right Cessation
- 1999-12-17 JP JP2000592029A patent/JP4649044B2/ja not_active Expired - Lifetime
- 1999-12-17 AU AU17004/00A patent/AU774991B2/en not_active Expired
- 1999-12-17 NZ NZ534618A patent/NZ534618A/xx not_active IP Right Cessation
- 1999-12-17 NZ NZ545023A patent/NZ545023A/en not_active IP Right Cessation
- 1999-12-17 WO PCT/NO1999/000392 patent/WO2000040275A2/en not_active Ceased
- 1999-12-17 NZ NZ513135A patent/NZ513135A/en not_active IP Right Cessation
- 1999-12-17 ES ES99960058T patent/ES2268888T3/es not_active Expired - Lifetime
- 1999-12-17 EP EP99960058A patent/EP1140212B1/en not_active Expired - Lifetime
- 1999-12-17 PT PT99960058T patent/PT1140212E/pt unknown
- 1999-12-17 AT AT99960058T patent/ATE331534T1/de active
- 1999-12-17 IL IL14413599A patent/IL144135A0/xx not_active IP Right Cessation
- 1999-12-17 TR TR2001/02707T patent/TR200102707T2/xx unknown
-
2000
- 2000-01-03 US US09/476,569 patent/US6635234B1/en not_active Expired - Lifetime
-
2001
- 2001-07-02 ZA ZA200105431A patent/ZA200105431B/en unknown
-
2003
- 2003-06-12 US US10/459,941 patent/US20030206857A1/en not_active Abandoned
-
2006
- 2006-09-28 CY CY20061101404T patent/CY1105634T1/el unknown
-
2010
- 2010-04-20 JP JP2010096736A patent/JP5433490B2/ja not_active Expired - Lifetime
-
2014
- 2014-04-09 LU LU92425C patent/LU92425I2/fr unknown
- 2014-05-07 BE BE2014C028C patent/BE2014C028I2/fr unknown
- 2014-05-09 NO NO2014010C patent/NO2014010I1/no not_active IP Right Cessation
- 2014-05-13 CY CY2014020C patent/CY2014020I1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL144135A0 (en) | The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning | |
| MY164077A (en) | Compositions and uses of et743 for treating cancer | |
| MXPA03006771A (es) | Anticuerpos modificados y metodos de uso. | |
| EP1143943A3 (en) | P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant | |
| HUP0200763A2 (en) | Compositions for the treatment and diagnosis of breast cancer and methods for their use | |
| IL149176A0 (en) | Therapeutic use | |
| NZ512659A (en) | Use of growth hormone secretagogues for treatment of physical performance decline | |
| AU2003250190A1 (en) | Combination of an aromatase inhibitor with a bisphosphonate | |
| WO2000061755A3 (en) | Secreted human proteins | |
| IL146794A0 (en) | Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues | |
| WO2004075977A3 (en) | Methods using diffuse field ultrasound-induced hyperthermia | |
| AU2002235991A1 (en) | Use of the g-csf as adjuvant treatment in connective tissue recontruction | |
| AU6739690A (en) | Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans | |
| UA32173A (uk) | Спосіб лікування недорозвиненої середньої зони лицевого скелету | |
| UA34639A (uk) | Банка медична | |
| UA33571A (uk) | Спосіб лікування травматичного перелому нижньої щелепи | |
| UA32302A (uk) | Спосіб усунення післяопераційних деформацій м'яких тканин | |
| SI1196159T1 (en) | Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues | |
| UA49353A (uk) | Спосіб лікування онкологічних захворювань | |
| UA32153A (uk) | Спосіб формування трансплантату для зведення на промежину при черевно-анальних резекціях прямої кишки | |
| AU2001240529A1 (en) | Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof | |
| UA29707A (uk) | Спосіб відновлення кісткових тканин при переломах |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GD | Licence granted | ||
| HC | Change of company name or juridical status |